Biomerica Inc. (BMRA)

Overview News Price History Option Chain Financials Why BMRA Down? Discussions Forecast Stock Split

Why is Biomerica Inc. (BMRA) Stock down?

We've noticed a 6.67% decline in Biomerica Inc. (BMRA) stock during the 2024-05-03 trading session. While this could be attributed to normal volatility or various internal and external factors, please be aware that we are actively monitoring the situation, and we'll provide timely updates as soon as possible!

21 Dec, 2023:

Shares of Biomerica Inc. (BMRA) dropped by 14.29% from $1.40 to $1.20 in the trading on Thursday, December 21, 2023. The reason why BMRA down today is due to the company announced that it had received FDA 510 (k) clearance for their Hp Detect ELISA test product and insider selling.

FDA 510(k) Clearance Announcement: Biomerica announced that it had received FDA 510(k) clearance for their Hp Detect ELISA test product. While FDA clearance is typically seen as a positive development, the stock's decline suggests that the market had already anticipated this clearance and factored it into the stock price. As a result, the news did not provide the anticipated boost to the stock.
Insider Selling: Biomerica filed multiple Form 4 disclosures on the same day, indicating changes in beneficial ownership of securities by company insiders. When insiders sell their shares, it can be interpreted as a sign of profit-taking or a lack of confidence in the company's future performance. This insider selling may have contributed to negative sentiment among investors.